Through experiments, Zhang et al. further confirmed that the inhibition of CXCR2 prevented and reversed hypertension-induced AF and atrial remodeling, providing evidence that CXCR2 might be a potential therapeutic target for AF [47]. Here, CXCR2 is linked to Hypertension.